Related Experiment Video
Updated: Apr 16, 2026

Electrocardiogram Recordings in Anesthetized Mice using Lead II
Published on: June 20, 2020
Computer-assisted interventions to improve QTc documentation in patients receiving QT-prolonging drugs
Kristin E Sandau1, Sue Sendelbach2, Linda Fletcher2
1Kristin E. Sandau is a professor of nursing at Bethel University, St Paul, Minnesota. Sue Sendelbach is director of nursing research at Abbott-Northwestern Hospital, Minneapolis, Minnesota. At the time of the study, Linda Fletcher was a senior business analyst at Allina Health, Minneapolis, Minnesota. Joel Frederickson is a professor and chair of the Department of Psychology at Bethel University. Barbara J. Drew is the David Mortara Distinguished Professor in Physiological Nursing Research and a clinical professor of medicine, cardiology at the University of California, San Francisco. Marjorie Funk is the Helen Porter Jayne and Martha Prosser Jayne Professor of Nursing at the Yale University School of Nursing, New Haven, Connecticut. k-sandau@bethel.edu.
Background:
Many medications commonly used in hospitals can cause prolonged corrected QT interval (QTc), putting patients at risk for torsade de pointes (TdP), a potentially fatal arrhythmia. However, documentation of QTc for hospitalized patients receiving QT-prolonging medications is often not consistent with American Heart Association standards.
Objective:
To examine effects of education and computerized documentation enhancements on QTc documentation.
Methods:
A quasi-experimental multisite study among 4011 cardiac-monitored patients receiving QTc-prolonging medications within a 10-hospital health care system was conducted to compare QTc documentation before (n=1517), 3 months after (n = 1301), and 4 to 6 months after (n = 1193) an intervention. The intervention included (1) online education for 3232 nurses, (2) electronic notifications to alert nurses when a patient received at least 2 doses of a QT-prolonging medication, and (3) computerized calculation of QTc in electronic health records after nurses had documented heart rate and QT interval.
Results:
QTc documentation for inpatients receiving QTc-prolonging drugs increased significantly from baseline (17.3%) to 3 months after the intervention (58.2%; P < .001) within the 10 hospitals and had increased further 4 to 6 months after the intervention (62.1%, P = .75). Patients at larger hospitals were significantly more likely to have their QTc documented (46.4%) than were patients at smaller hospitals (26.2%; P < .001).
Conclusion:
A 3-step system-wide intervention was associated with an increase in QTc documentation for patients at risk for drug-induced TdP, and improvements persisted over time. Further study is needed to assess whether increased QTc documentation decreases occurrence of drug-induced TdP. (American Journal of Critical Care. 2015;24:e6-e15).
Related Concept Videos
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Dysrhythmias VI: Management of Dysrhythmias
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Dysrhythmias VII: Nursing Management of Dysrhythmias

